The global gabapentin market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.13% during 2024-2032. There are many factors that are driving the market, which include rising neuropathic conditions, increasing drug versatility in treating off-label drugs, ongoing opioid crises, fa... https://www.imarcgroup.com/gabapentin-market